Investigating the effect of diclofenac suppository on nausea and vomiting

The investigating the effect of preoperative diclofenac suppository on opioid consumptiom and nausea and vomiting in maxillofacial surgeries

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200606047664N1

Enrollment

Registered

2020-07-12

Start date

2019-08-23

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting. Nausea and vomiting

Interventions

Intervention 1: Intervention group: Diclofenac suppository 100 mg preoperation and Diclofenac suppository 50 mg postoperation. Intervention 2: Control group: Glycerin suppository 100 mg preoperation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients required IMF post maxillofacial surgeries

Exclusion criteria

Exclusion criteria: pregnancy coaglupathy disfunction heart, liver, kidney and gasterointestinal disease history addiction history

Design outcomes

Primary

Measure	Time frame
Nausea. Timepoint: after recovery, 6 hours post operation, 12 hours post operation. Method of measurement: According to the questionnaire using symptom of nausea.;Vomiting. Timepoint: after recovery, 6 hours post operation, 12 hours post operation. Method of measurement: According to the questionnaire using sign of vomiting.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed mojtaba Alavikia

Yazd University of Medical Sciences

sm.alavikia@spu.ssu.ac.ir+98 35 3624 7450

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026